CRX is an intrinsic suppressor of epithelial‒mesenchymal transition in retinal pigment epithelial cells: a promising therapeutic avenue for subretinal fibrosis
Dongli Li, Qingjian Ou, Furong Gao, Xi Wang, Lilin Zhu, Ye Zhou, Jing-Ying Xu, Caixia Jin, Juan Wang, Jieping Zhang, Jiao Li, Yanlong Bi, Lixia Lu, Guo-Tong Xu, Haibin Tian · 2025
Read CRX is an intrinsic suppressor of epithelial‒mesenchymal transition in retinal pigment epithelial cells: a promising therapeutic avenue for subretinal fibrosis by Dongli Li, Qingjian Ou, Furong Gao, Xi Wang, Lilin Zhu, Ye Zhou, Jing-Ying Xu, Caixia Jin, Juan Wang, Jieping Zhang, Jiao Li, Yanlong Bi, Lixia Lu, Guo-Tong Xu, Haibin Tian (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12859066.txt.
Description
Dongli Li and co-authors find a built-in brake on a harmful cell change in the eye's pigment layer, in work from 2025. That change helps drive scar tissue under the retina in age-related macular degeneration. Many paths that push the change were known, but paths that hold it back inside the cells were not.
The brake is a protein called CRX, best known from light-sensing cells. Two signal paths together switch CRX off by moving a partner protein into the nucleus. Restoring CRX blocked the harmful change in lab-grown pigment cells, partly through a second protein it raises. Tests in a mouse eye model backed the effect. The authors propose CRX as a drug target.
Catalog record
| CREATOR | Dongli Li, Qingjian Ou, Furong Gao, Xi Wang, Lilin Zhu, Ye Zhou, Jing-Ying Xu, Caixia Jin, Juan Wang, Jieping Zhang, Jiao Li, Yanlong Bi, Lixia Lu, Guo-Tong Xu, Haibin Tian |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |